Reata Pharmaceuticals Inc (NASDAQ:RETA)
| 27.60 Delayed Data As of 4:01pm ET |  -1.07 / -3.73%Today’s Change | 25.02 Today|||52-Week Range 153.41 | +4.66% Year-to-Date |
Latest RETA News | Press Releases
No recent news for Reata Pharmaceuticals Inc.
Today’s Trading
| Previous close | 28.67 |
| Today’s open | 28.05 |
| Day’s range | 27.41 - 29.18 |
| Volume | 47,935 |
| Average volume (3 months) | 626,801 |
| Market cap | $1.0B |
Data as of 4:01pm ET, 01/18/2022
Growth & Valuation
| Earnings growth (last year) | +22.97% |
| Earnings growth (this year) | -10.09% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -65.99% |
| P/E ratio | NM |
| Price/Sales | 462.04 |
| Price/Book | 2.49 |
Competitors
| ---- | ||
| ---- | ||
| INOInovio Pharmaceutica... | -0.47 | -9.89% |
| --Fountain Healthy Agi... | 0.00 | 0.00% |
Data as of 4:47pm ET, 01/18/2022
Financials
| Next reporting date | March 4, 2022 |
| EPS forecast (this quarter) | -$2.26 |
| Annual revenue (last year) | $9.0M |
| Annual profit (last year) | -$247.8M |
| Net profit margin | -2,747.00% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Plano, Texas |
Forecasts
